Signal sequence that induces protein secretion in intestinal microbiome
US-2024190925-A1 · Jun 13, 2024 · US
US2023044825A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2023044825-A1 |
| Application number | US-202017782366-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 4, 2020 |
| Priority date | Dec 6, 2019 |
| Publication date | Feb 9, 2023 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Proteins and fusion proteins for forming merbraneless droplets in cells are provided. Described herein, is the development of a protein, named PopTag, that drives phase separation when it is part of a chimeric fusion protein. PopTag is engineered from the PopZ protein, found in a-proteobacteria (including Caulobacter crescentus ). Despite PopZ being exclusively found in this clade of bacteria, the PopTag can drive protein phase separation in other prokaryotes (e.g., E. coli ) and eukaryotes (e.g., human cells).
Opening claim text (preview).
1 . A fusion protein comprising an amino acid sequence linked to a polypeptide sequence comprising SEQ ID NO: 1, or a variant thereof as set forth in Table 1, wherein the amino acid sequence is heterologous to the polypeptide sequence. 2 . The fusion protein of claim 1 , wherein the polypeptide sequence is at least 95% identical to SEQ ID NO: 1. 3 . The fusion protein of claim 1 , wherein the amino acid sequence is an epitope-binding polypeptide. 4 . The fusion protein of claim 3 , wherein the epitope-binding polypeptide comprises an immunoglobulin heavy chain variable region. 5 . The fusion protein of claim 4 , wherein the epitope-binding polypeptide is a single domain antibody or a single-chain variable fragment (scfv). 6 . The fusion protein of claim 1 , wherein the amino acid sequence is a target-binding polypeptide. 7 . The fusion protein of claim 1 , wherein the amino acid sequence comprises a fluorescent protein. 8 . The fusion protein of claim 1 , wherein the amino acid sequence comprises an enzyme. 9 . A polynucleotide comprising a nucleic acid sequence that encodes the fusion protein of claim 1 . 10 . The polynucleotide of claim 9 , comprising a promoter operably linked to the nucleic acid sequence. 11 . (canceled) 12 . A cell comprising a polynucleotide encoding the fusion protein of claim 1 , wherein the cell expresses the fusion protein. 13 . The cell of claim 12 , wherein the cell is a eukaryotic cell. 14 . The cell of claim 13 , wherein the eukaryotic cell is a mammalian cell. 15 . The cell of claim 13 , wherein the eukaryotic cell is a plant or yeast cell. 16 . The cell of claim 12 , wherein the cell comprises: a. a first polynucleotide encoding a first fusion protein and; b. a second polypeptide encoding a second fusion protein, wherein the first fusion protein and the second fusion protein comprise a polypeptide sequence comprising SEQ ID NO: 1 or a variant thereof as set forth in Table 1 and comprise different heterologous amino acid sequences. 17 . The cell of claim 16 , wherein the different heterologous amino acid sequences are different enzymes. 18 . A method of purifying a product from a cell, the method comprising, expressing in the cell the fusion protein of claim 1 , wherein the fusion protein forms compartments in the cell; optionally performing a reaction in the compartments to form the product; lysing the cell; and isolating the compartments from cell lysate material, wherein the compartments comprise the product, thereby purifying the product from the cell. 19 . The method of claim 18 , wherein the product is formed by performing a product in the compartments. 20 . The method of claim 19 , wherein the amino acid sequence comprises an enzyme and the enzyme catalyzes production of the product. 21 . The method of claim 18 , wherein the cell produces the product and the amino acid sequence comprises a binding polypeptide that binds the product, thereby binding the product to the compartment. 22 - 23 . (canceled)
containing a domain for self-assembly, e.g. a viral coat protein (includes phage display) · CPC title
from bacteria · CPC title
having a known sequence of two or more amino acids, e.g. glutathione · CPC title
Single chain antibody (scFv) · CPC title
DNA sequences coding for fusion proteins · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.